Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01112735 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of ARTISS for Flap Adherence in Abdominoplasty
A Phase 2 study, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT01112735 is a Phase 2 study that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 40 participants.
The verdict
NCT01112735, a Phase 2 study, has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the safety and efficacy of ARTISS versus standard of care in adhering tissue places and reducing seroma/hematoma formation in subjects undergoing abdominoplasty.
Interventions
- PROCEDURE Standard of care
- BIOLOGICAL FS VH S/D 4 s-apr (= two-component fibrin sealant, double virus inactivated, made from pooled human plasma)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01112735
The ClinicalTrials.gov registry entry for NCT01112735 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of care is the first listed.
NCT01112735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01112735 about?
NCT01112735 is a clinical study titled "Efficacy and Safety of ARTISS for Flap Adherence in Abdominoplasty". The purpose of the study is to compare the safety and efficacy of ARTISS versus standard of care in adhering tissue places and reducing seroma/hematoma formation in subjects undergoing abdominoplasty.
What is the current status of trial NCT01112735?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2010-05. Estimated completion is 2011-02.
What interventions are being tested in trial NCT01112735?
The interventions under investigation include: Standard of care (PROCEDURE), FS VH S/D 4 s-apr (= two-component fibrin sealant, double virus inactivated, made from pooled human plasma) (BIOLOGICAL).
Who is sponsoring clinical trial NCT01112735?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.